Quadria Group has launched HealthQuad Fund III with a proposed raise of up to$300 million (target corpus of $200 million with a green shoe option of $100 million).

With its third fund, the private equity player plans to build a portfolio of healthcare ventures that have significantly expanded access, affordability, and quality of care across India.

Dr. Amit Varma, Co-founder and Investment Committee member, HealthQuad, said, “India presents one of the world’s most compelling healthcare investment opportunities – driven by growing demand, digital acceleration, and underserved segments across primary, diagnostic, and chronic care. We are better positioned than ever to deliver cross-regional value for our portfolio companies, across South Asia, Southeast Asia, and the GCC, creating an unparalleled platform for health innovation.”

Through this new fund, Quadria Group intends to combine its pan-Asian network, institutional investor base, and operational expertise to deliver scaled impact and value. The Group recently closed Quadria Capital Fund III at US$1.07 billion, with a strong backing from leading global institutions.

Founded in 2012, Quadria Capital is Asia’s premier healthcare investor managing over $4 billion in assets across 27 investments in South and Southeast Asia including India, Vietnam, Indonesia, Malaysia and Singapore. In India, Quadria Group has backed over 18 companies including Qure.ai, Medikabazaar, THB, Wysa, Ekincare, Redcliffe Labs, GoApptiv, and Strand Life Sciences.

Published on June 17, 2025